Logistic regression analysis of factors associated with failure to proceed to undergo HCT
| Variable . | Effect . | OR . | 95% CI . | P value . |
|---|---|---|---|---|
| Age | Per 10-y increment | 1.50 | 1.21--1.86 | < .001 |
| Race | Black vs White | 2.05 | 1.11--3.79 | .023 |
| Diagnosis and disease risk | AML–poor risk vs AML–intermediate risk | 2.23 | 1.09--4.58 | .029 |
| ALL-standard risk vs AML–intermediate risk | 3.26 | 0.92--11.55 | .07 | |
| ALL-poor risk vs AML–intermediate risk | 1.55 | 0.66--3.64 | .31 | |
| MDS- vs AML–intermediate risk | 0.65 | 0.15--2.87 | .57 |
| Variable . | Effect . | OR . | 95% CI . | P value . |
|---|---|---|---|---|
| Age | Per 10-y increment | 1.50 | 1.21--1.86 | < .001 |
| Race | Black vs White | 2.05 | 1.11--3.79 | .023 |
| Diagnosis and disease risk | AML–poor risk vs AML–intermediate risk | 2.23 | 1.09--4.58 | .029 |
| ALL-standard risk vs AML–intermediate risk | 3.26 | 0.92--11.55 | .07 | |
| ALL-poor risk vs AML–intermediate risk | 1.55 | 0.66--3.64 | .31 | |
| MDS- vs AML–intermediate risk | 0.65 | 0.15--2.87 | .57 |